Please login to the form below

Not currently logged in
Email:
Password:

McCann Health expands consulting team

Two new managing directors appointed

Business consultancy McCann Health has appointed two new managing directors - Robert Paglia and Randy Goodman - to the firm as a result of expanding projects.

Prior to McCann Health, Robert Paglia has held a number of senior roles such as US head, pricing and market access for PriceSpective, founder and president of Evolution Health Initiatives and various sales and marketing positions at Johnson & Johnson, Purdue Pharma and Bristol-Myers Squibb.

In addition to Paglia, Randy Goodman joins McCann Health bringing more than 23 years of experience from both the public and private sector.

Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.

Goodman also worked for the White House office on reform and health policy during both the Clinton and Obama administrations.

Simon Holt, president of consulting at McCann Health, said: “We’re delighted to welcome two new senior executives to the NY management team with expertise in developing new approaches to meet the needs of today’s customers, more effective market access and pricing solutions, and fresh approaches to embedding the latest marketing and business strategies into entire organisations.”

11th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
arrow
The false economy of following the leader
How can companies in the sector shake things up?...

Infographics